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Abstract
Background Arterial and thromboembolic pulmonary
hypertension (PH) lead to arterial hypoxaemia.
Objective To investigate whether cerebral tissue oxy-
genation (CTO) in patients with PH is reduced and whether
this is associated with reduced exercise tolerance.
Methods 16 patients with PH (mean pulmonary arterial
pressure C25 mmHg, 14 arterial, 2 chronic thromboem-
bolic) and 15 controls underwent right heart catheterisation
with monitoring of CTO at rest, during maximal bicycle
exercise and during inhalation of oxygen and NO. The
6 min walk distance (6MWD) was measured.
Results Median CTO in PH-patients at rest was 62 %
(quartiles 53; 71), during exercise 60 % (53; 65); corre-
sponding values in controls were 65 % (73; 73) (P = NS)
and 68 % (66; 70) (p = .013 vs. PH). Inhalation of NO and
oxygen improved CTO in PH. In multivariate regression
analysis CTO at maximal exercise predicted the work load
achieved when controlled for age, pulmonary vascular
resistance and mixed venous oxygen saturation (R2 = .419,
p\ .000); in addition, the 6MWD was predicted by CTO
(adjusted R2 = .511, p\ .000).
Conclusion In PH-patients but not in controls CTO
decreased during exercise. Since CTO was an independent
predictor of the work load achieved and the 6MWD cere-
bral hypoxia may contribute to exercise limitation in PH.
Clinicaltrials.gov: NCT01463514.
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Abbreviation
CTEPH Chronic thromboembolic pulmonary
hypertension
CtHb Cerebral total haemoglobin
CTO Cerebral tissue oxygenation
mPAP Mean pulmonary artery pressure
NIRS Near infrared spectroscopy
NO Nitric oxide
NYHA New York Heart Association
PAH Pulmonary arterial hypertension
PH Pulmonary hypertension
PVR Pulmonary vascular resistance
QMtHb Quadriceps muscle total haemoglobin
QMTO Quadriceps muscle tissue oxygenation
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Introduction
Precapillary pulmonary hypertension (PH) is defined by a
mean pulmonary artery pressure (mPAP) C25 mmHg
along with a pulmonary artery wedge pressure B15 mmHg
[1]. PH is associated with various diseases and leads to
progressive functional impairment, reduced quality of life
and premature death. In the absence of lung diseases, the
two major groups of PH are pulmonary arterial hyperten-
sion (PAH), including idiopathic and associated forms, and
chronic thromboembolic PH (CTEPH) [1, 2].
With progressing disease, patients develop increasing
hypoxaemia due to reduced cardiac output resulting in a low
mixed venous oxygen saturation, ventilation perfusion
mismatch and a decreased pulmonary capillary bed [3]. As a
consequence, tissue oxygenation may decrease and impair
important physiological functions including those of the
brain and the muscles [4, 5]. However, whether cerebral and
muscle tissue oxygenation are reduced at rest and during
exercise has not been rigorously studied in PH-patients. The
aim of the current study was therefore to investigate the
patterns of cerebral (CTO) and quadriceps muscle oxy-
genation (QMTO) using non-invasive near infrared spec-
troscopy (NIRS) along with pulse oximetry in PH-patients
at rest and during maximal exercise, and in response to
inhalation of oxygen and nitric oxide (NO). We hypothe-
sized that cerebral and muscle tissue oxygenations in PH
would be reduced in association with impaired exercise
tolerance, and could be improved by oxygen or inhaled NO.
Methods
Study Design
Patients with PH and controls without PH undergoing right
heart catheterisation (RHC) had hemodynamic and NIRS
evaluations at rest breathing either roomair, oxygen orNO, all
applied in randomorderwith the patients blinded to respective
treatments, and thereafter during supine bicycle exercise.
Patients
From October 2011 to March 2013, all patients ([18y) of
both genders scheduled for RHC due to unexplained
dyspnoea and suspected PH were eligible upon written
informed consent. Patients were excluded if they had sig-
nificant comorbidity e.g. left heart disease with a pul-
monary capillary wedge pressure C15 mmHg, active
psychiatric or neurologic disease, lung disease (forced
expiratory volume in 1’’ and vital capacity \70 % pre-
dicted), renal dysfunction or other relevant comorbidity.
The study was approved by the institutional ethics com-
mittee and registered (Clinicaltrials.gov, NCT01463514).
Assessments
Demographics and medical history were noted and physi-
cal examination performed. The 6 min walk distance
(6MWD) was measured [6].
Right Heart Catheterization
A Swan-Ganz catheter (Swan Ganz CCOmbo V, 8F,
Edwards Lifesciences, Irvine, CA 92614, USA) was placed
in the pulmonary artery via the right jugular vein. The
transducer was placed at 60 % of the back-sternum dis-
tance at the presumptive level of the right atrium and
zeroed to atmospheric pressure. The following parameters
were recorded: heart rate (HR), mean arterial and pul-
monary artery pressure (mPAP), pulmonary artery wedge
pressure and right atrial pressure. The cardiac output was
continuously measured by thermodilution (Vigilance II,
Edwards Lifesciences, Irvine CA 92614, USA), and the
mixed venous oxygen saturation (SmvO2) was assessed.
The mean pressures were calculated as 2x diastolic and 1x
systolic PAP/3. Systemic and pulmonary vascular resis-
tance (PVR) were calculated. Selected variables were
indexed to body surface area.
Blood Analysis and Oximetry
Arterial and mixed venous blood gases were immediately
analysed at baseline and after 100 % oxygen administra-
tion (ABL 90 Flex-blood analyzer, Radiometer GmbH).
Pulse oximetry was continuously monitored.
Cerebral and Muscle Tissue Oxygenation by NIRS
CTO and QMTO were recorded by NIRS along with
changes in cerebral and muscle total haemoglobin con-
centration (CtHb, MtHb) at a sampling rate of 1/6 Hz
(INVOS, Somanetics Corporation, Troy, Michigan,
USA). Two optic sensors (optodes) were placed on the
left and right forehead above the frontal sinus and at
both thighs at the ventral mid-level of the quadriceps
muscles.
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Interventions During Right Heart Catheterization
and Randomization
The following inhalative interventions were performed over
10 min each in a randomized order with the patients blinded
to the corresponding treatment. Awash-out period of 10 min
separated each application. For randomization, patients had
to draw a sequence number from an envelope. After another
10 min of rest, patients performed supine progressive cycle
test (TheraVital, Medica Medizintechnick GmbH,
Germany) starting with 10 Watts followed by an increase of
10 Watt every 3 min to exhaustion.
Data Analysis and Statistics
Hemodynamic and NIRS measures were averaged over the
last minute of baseline and each intervention (room air,
oxygen and nitric oxide) and over the final minute of maxi-
mal exercise. Mean NIRS data from the left and right body
sites are reported. The CtHb and QMtHb were calculated as
the sum of oxygenated plus deoxygenated haemoglobin
concentration and given in arbitrary units. Themain outcome
was the CTO, secondary outcomes were the QMTO, arterial
oxygen saturation and hemodynamic variables.
As most data were not normally distributed, they were
summarized by medians (quartiles). Differences between
and within groups (PH-patients vs. controls) were calcu-
lated using the Mann–Whitney U test and the Wilcoxon
matched pair test, respectively. Pearson correlation and
multivariate regression analyses were used to evaluate
associations of CTO with several physiological and clinical




The patient flow is illustrated in Fig. 1. The analysis
includes data from 16 patients (11 females) diagnosed with
Fig. 1 The flow of patients scheduled for right heart catheterisation
and included or excluded to the study is shown. NIRS near infrared
spectrometry, RHC right heart catheter, mPAP mean pulmonary
arterial pressure, CTD connective tissue disease
Table 1 Characteristics for
PH-patients and controls
Medians (quartiles) or number
(%).
PH pulmonary hypertension,
BMI body mass index, NYHA
New York Heart Association
functional class, U Units, mPAP
mean pulmonary artery pressure
* p\ .05 vs. controls.
Patients
(mPAP C 25 mmHg)
Controls (mPAP\ 25 mmHg)
Number of participants 16 (11 females) 15 (10 females)
Age (year) 66 (49, 70) 51 (43, 66)
BMI, kg/m2 29 (24, 32) 25 (22, 29)
NYHA Class (I, II, III, IV) 1 (6 %), 2 (13 %), 9 (56 %),
4 (25 %)
3 (20 %), 6 (40 %), 3 (20 %),
3 (20 %)
6 min walk distance (m) 452 (342, 503)* 520 (510, 591)
Work load during supine cycling (Watt) 30 (20; 40)* 50 (40; 60)
Classification, n (%)
PH-patients mPAP C 25 mmHg
Pulmonary arterial hypertension 14 (87.5 %) NA
Idiopathic 12 (75 %)
Connective tissue disease 2 (12.5 %) NA
Chronic thromboembolic 2 (12.5 %)
Controls mPAP\ 25 mmHg
Connective tissue disease without PH NA 5 (33 %)
Other reasons for dyspnoea
(Lung- or heart diseases without PH,
deconditioning)
NA 10 (67 %)
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PH (mPAP C 25 mmHg, 12 idiopathic PAH, 2 associated
with connective tissue disease, 2 CTEPH), and from 15
non-PH controls (mPAP\ 25 mmHg), 5 scleroderma-
patients without PH, 10 patients with other causes of
dyspnea: deconditioning, lung and heart diseases without
PH. Baseline characteristics are listed in Table 1.
Baseline Measurements and Response to Exercise
According to the selection criteria, we found highly sig-
nificant differences in baseline mPAP between PH and
controls (Tables 1, 2). Patients with PH had a higher heart
rate and PVR and a lower SpO2 and SmvO2. The resting
room air baseline CTO, QMTO, CtHb and QMtHb were
similar in patients and controls (Table 2; Fig. 2).
During maximal exercise, there was a significantly
higher mPAP and PVR along with a lower cardiac index
and a lower SpO2 and SmvO2 in PH-patients compared
with controls (Table 2; Fig. 2). As CTO in PH-patients
tended to fall during exercise, but increased in controls the
values of CTO during maximal exercise were significantly
lower in patients than in controls. The CtHb was similar in
both groups with exercise; however, it increased signifi-
cantly from baseline in PH-patients at maximal exercise.
QMTO decreased with exercise in PH-patients but not in
controls. The QMtHb remained unchanged.
CTO at rest was negatively correlated with age (R =
-.498, p = .004), NYHA functional class (R = -.469,
p = .008) and PVR (R = -.418, p = .019). CTO at rest
was positively correlated with the SpO2 (R = .376,
p = .037), SmvO2 (R = .670, p\ .000), the maximal
work load in watt achieved (R = .616, p\ .000) and the
6MWD (R = .715, p\ .000, Fig. 3a), whereas QMTO did
not correlate with the 6MWD (R = .323, p = .094,
Fig. 3b). CTO at maximal exercise was negatively corre-
lated with the PVR (R = -.660, p\ .000) and positively
correlated with the 6MWD (R = .713, p\ .000) and
maximal workload achieved (R = .662, p\ .000). In a
multiple regression model including age, CTO, SmvO2 and
PVR, the resting CTO was the best independent predictor
Table 2 Measurements at rest and during supine maximal bicycle exercise in patients with PH and controls
Rest Maximal exercise
PH Controls p# PH Controls p#
Pulmonary hemodynamics and blood oxygenation
Heart rate (1/min) 85 72 .022 101* 110* .787
(69, 92) (62, 75) (95, 121) (99, 122)
Mean arterial pressure (mmHg) 96 91 .128 122* 103* .029
(89, 106) (78, 98) (112, 129) (91, 120)
Mean pulmonary artery pressure (mmHg) 37 18 .000 54* 29* .000
(32, 48) (17, 20) (51, 65) (23, 34)
Cardiac index (l/min) 3.2 3.2 .711 3.5* 4.7* .031
(2.6, 3.6) (2.7, 3.8) (3.0, 4.1) (3.9, 5.1)
Pulmonary vascular resistance (WU) 4.9 1.2 .000 6.3* 1.5* .000
(2.7, 6.4) (0.9, 1.5) (4.6, 8.0) (1.2, 2.5)
Arterial oxygen saturation (%) 89 95 .001 88 96 .000
(83, 94) (94, 96) (76, 92) (94, 98)
Mixed venous oxygen saturation (%) 63 72 .027 35* 45* .002
(58, 71) (68, 74) (26, 38) (38, 54)
Near infrared spectroscopy
Cerebral tissue oxygenation (%) 62 65 .213 60 68 .010
(53, 71) (63, 73) (53, 65) (66, 70)
Cerebral total haemoglobin (unit) 23 22 .470 27* 24 .782
(20, 28) (19, 26) (21, 30) (21, 32)
Quadriceps tissue oxygenation (%) 79 78 .446 72* 78 .251
(68, 82) (76, 87) (58, 81) (69, 83)
Quadriceps total haemoglobin (unit) 21 21 .800 21 19 .553
(19, 21) (19, 22) (16, 24) (16, 26)
Medians (quartiles). PH precapillary pulmonary hypertension defined as mean pulmonary artery pressure C25 mmHg with a pulmonary artery
wedge pressure\15 mmHg
#
p for comparisons between groups; * p\ .05 compared with rest within group. WU Wood units
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of the 6MWD (adjusted R2 = .511, p\ .000). If the same
model was applied with the QMTO instead of the CTO, the
QMTO did not predict the 6MWD (p = .773). In the
multiple regression model, CTO at maximal exercise was
an independent predictor of the work load in watt achieved
(adjusted R2 = .419, p\ .000) and the 6MWD (adjusted
R2 = .489, p\ .000) in respective models including for
age, SmvO2 and the PVR. If the same models were applied
with the QMTO instead of the CTO at maximal exercise,
the QMTO at maximal exercise did neither predict the
6MWD (p = .716) nor the maximal work load achieved
(p = .160).
Effect of Oxygen and Nitric Oxide
Compared to room air breathing at rest (see values in
Table 2), inhalation of 100 % oxygen led to significant
decreases in heart rate and mPAP along with significant
increases in SpO2, SmvO2, CTO and QMTO in PH-patients
and controls. The decrease in mPAP and the increases in
SpO2, SmvO2, CTO and QMTO were greater in PH com-
pared with controls, resulting in similar oxygenation vari-
ables in both groups (Table 3; Fig. 2). CtHb under oxygen
was higher in PH-patients compared with controls, the
QMtHb was similar.
Compared to air breathing at rest (see values in
Table 2), inhalation of NO led to a significant decrease in
mPAP along with a significant increase in SpO2, SmvO2
and QMTO in both, patients and controls (Table 3). NO
significantly decreased heart rate and increased CTO in
PH-patients only. The increase in QTMO with NO was
higher in PH-patients compared with controls.
The increase in CTO with oxygen breathing was cor-
related with the decrease in mPAP (R = -.452, p = .011)
Fig. 2 Arterial oxygen
saturation (%), mixed venous
saturation (%) and cerebral
tissue oxygenation (%) are
shown for patients with
pulmonary hypertension (PH-
patients) and controls without
PH during supine rest (baseline,
breathing room air) and during
bicycle exercise (left panels a to
c) and during 100 % oxygen
breathing and NO inhalation
(right panels, d to f). #p\ .05
compared with respective
baseline. *p\ .05 between PH-
patients and controls
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and the increase in SpO2 and SmvO2 (R = .695, p\ .000
and R = .483, p = .006, respectively). Regression analysis
revealed that this increase in CTO with oxygen breathing
was significantly correlated with the decrease in mPAP
(p = .011) even when controlled for age.
Under nitric oxide breathing, we found a negative cor-
relation between CTO and PVR (R = -.391, p = .033)
and a positive correlation between CTO and SmvO2
(R = .482, p = .007). The increase in CTO under NO
significantly correlated with the increase in SmvO2
(R = .400, p = .028).
Discussion
The purpose of this study was to evaluate cerebral, muscle
and arterial oxygenation in PH-patients at rest and in
response to exercise and inhalation of oxygen and NO in
comparison to controls without PH. Our data confirm the
hypothesis that exercise was associated with a significantly
lower CTO in PH-patients compared with controls. Oxygen
breathing improved CTO in both patients and controls but
to a greater degree in PH-patients. Nitric oxide increased
CTO in PH-patients but not in controls. Since multiple
regression analysis indicated that CTO in PH-patients was
an independent predictor of the maximal work load
achieved and the 6MWD, our data suggest that exercise
performance of PH-patients is not only limited by the
impaired pulmonary circulation but also by the associated
reduction in cerebral oxygenation.
With progressing disease, precapillary PH is associated
with a decreased arterial and mixed venous oxygenation
mainly due to a decreased cardiac output, a diminished
pulmonary capillary bed, ventilation perfusion mismatch
and intrapulmonary shunts may additionally play a role [3,
7]. Hypoxaemia in PH is even more pronounced during
exercise and sleep and these conditions might result in
profound tissue hypoxia [8–10]. For the first time, we used
NIRS to non-invasively and simultaneously monitor oxy-
genation of the brain and of exercising muscles of patients
with and without PH in order to better understand the
mechanisms of exercise limitation in PH and to evaluate
the effects of oxygen and NO in affected patients [4, 5, 11].
In our study, CTO at rest and maximal exercise was an
independent predictor of exercise performance, even in
multivariatemodels adjusted for known limiting factors such
as age, PVR and SmvO2, whereas QMTO was not (Fig. 3).
These findings are interesting and might suggest that a
decreasing CTO with progressive disease may reduce motor
neuron activation and thereby add to the limited exercise
performance of PH-patients [5, 12]. We found that the CTO
was significantly lower in PH compared to controls during
exercise (Table 2). If one bears in mind that our controls
were not healthy controls but rather patients with dyspnoea
of various aetiologies other than PH [1], we expect that the
difference in CTO between the current PH-patients and
healthy controls would be even more pronounced. Studies
have shown that in healthy subjects, CTO remains constant
during low- and middle intensity exercise, whereas it falls in
very hard exercise [5, 11, 13]. Training in healthy subjects is
associated with smaller decrease in CTO during exercise [5,
13, 14]; whether the improvement in the 6MWDexperienced
by certain PH-patients with exercise training is related to
improvements in CTO has not been studied. In patients with
cardiorespiratory diseases, CTO during exercise was mostly
lowered or unchanged, in line with our findings [15]. Thus,
Fig. 3 a The significant correlation of the cerebral tissue oxygenation
with the 6 min walk distance is shown. The correlation remained
highly significant in models including age, mixed venous oxygen
saturation and vascular resistance. b The lack of correlation of the
quadriceps muscle oxygenation with the 6 min walk distance is
shown
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cerebral oxygenation might be a limiting factor for maximal
exercise performance [16], which is supported by our results.
Studies have shown that age influences regional CTO and
that older subjects may recruit other areas of the brain to
complete cognitive tasks [17]. In our collective, age corre-
lated with CTO, however, age did not significantly add
information in models including CTO at rest and exercise,
blood oxygenation or pulmonary haemodynamics in order to
predict exercise capacity. Thus, CTO was the best predictor
of exercise performance and even a better predictor com-
pared with age, blood oxygenation and haemodynamics
(Fig. 3). An improved CTO under hyperoxia was associated
with increased exercise capacity in healthy untrained men
[18] and in patients with terminal lung diseases [15].
Hyperoxia given to healthy subjects at the point of exhaus-
tion during cycling at hypoxic condition led to continuation
of exercise at higher power outputs and the authors con-
cluded that the limiting factor to endurance exercise per-
formance was not the contractile muscle dysfunction but
rather the central motor drive to active muscle [19].
In our PH collective, exercise was associated not only
with a reduced CTO, but also reduced QMTO. Inadequate
O2 delivery to the skeletal muscle relative to O2 demands
potentially influences the response profile of muscle O2
extraction and impairs the intramyocytic metabolic
machinery leading to increased muscle fatigability and
reduced exercise tolerance in PH [4, 20]. In addition to
skeletal, also respiratory muscles might suffer from
reduced tissue oxygenation and herewith contribute to
exercise limitation in PH [21]. However, in our collective,
QMTO at rest or maximal exercise was not correlated with
the work load achieved during cycling nor the 6MWD.
Thus, CTO decline might more be a limiting factor in our
PH-patients and not the decline in QMTO.
Another focus of our study was to get insight into acute
CTO response to vasodilator therapies. We demonstrated for
the first time in PH-patients that the pulmonary vasodilators
oxygen and inhaled NO both significantly increased CTO
and QMTO along with improved pulmonary hemodynamics
and arterial oxygenation (Table 3). Since cardiac index and
Table 3 Effect of inhaled oxygen and nitric oxide in patients with pulmonary hypertension and controls
Oxygen Nitric oxide
PH Controls p# PH Controls p#
Pulmonary hemodynamics and blood oxygenation
Heart rate (1/min) 79* 66* .020 78* 69 .053
(67, 85) (61, 72) (67, 87) (63, 75)
Mean arterial pressure (mmHg) 98 91 .173 99 95 .383
(89, 104) (79, 99) (87, 109) (85, 102)
Mean pulmonary artery pressure (mmHg) 31* 15* .000 35* 15* .000
(26, 43) (14, 17) (27, 45) (14, 18)
Cardiac index (l/min) 3.0 2.9 .905 3.1 3.1 .546
(2.5, 3.2) (2.5, 3.8) (2.6, 3.7) (2.7, 4.0)
Pulmonary vascular resistance (WU) 3.6* 0.9 .000 3.9 0.9 .000
(2.9, 5.0) (0.7, 1.4) (2.3, 5.1) (0.7, 1.3)
Arterial oxygen saturation (%) 98* 97* .767 93* 97* .000
(97, 98) (97, 98) (90, 96) (96, 100)
Mixed venous oxygen saturation (%) 76* 80* .138 68* 75* .104
(71, 80) (77, 83) (60, 77) (69, 78)
Near infrared spectroscopy
Cerebral tissue oxygenation (%) 74* 72* .635 67* 67 .505
(69, 84) (69, 81) (58, 74) (64, 76)
Cerebral total haemoglobin (unit) 25 19 .031 22 20 .429
(21, 30) (17, 25) (19, 28) (16, 24)
Quadriceps tissue oxygenation (%) 86* 84* .797 81* 81* .588
(77, 89) (82, 93) (74, 86) (76, 88)
Quadriceps total haemoglobin (unit) 20 20 .632 21* 21 .472
(20, 24) (19, 22) (20, 25) (20, 22)
Data given as median (IQR). PH precapillary pulmonary hypertension defined as mean pulmonary artery pressure C25 mmHg with a pulmonary
artery wedge pressure\15 mmHg.
#
p for comparison between groups; * p\ .05 compared within groups with respective room air resting values are listed in Table 2
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systemic blood pressure did not change with oxygen or with
NO inhalation in PH-patients, the improvement in CTOwith
these therapeutics seems to be related to the improved arte-
rial oxygen saturation and oxygen delivery to the brain. In
controls, inhalation of NO did not improve CTO, consistent
with the lack of hemodynamic changes. Our results in PH-
patients are in line with studies in preterm new-born lambs in
which administration of iloprost and inhaled NO improved
pulmonary hemodynamics and prevented CTO dips [22].
Moreover, in human infants post-operative after cardiac
surgery intravenous sildenafil showed a significant increase
in CTO underpinning the relevance of improvements in
pulmonary circulation for cerebral oxygenation in condi-
tions with PH [23].
In summary, in this first study investigating CTO in PH-
patients compared to controls, we found that exercise
resulted in a significantly lower CTO in patients compared
with controls. Since CTO was correlated independently
with the 6MWD in multiple regression models corrected
for age and other markers of disease severity these findings
may indicate that a reduced cerebral oxygenation may
contribute to exercise limitation in PH-patients. Supple-
mental oxygen increased CTO to a significantly greater
extent in PH-patients compared with controls. Inhaled
nitric oxide improved CTO in PH-patients but not in con-
trols with normal PVR. Whether long-term vasodilator or
oxygen therapy would persistently improve CTO in PH-
patients and potentially increase exercise capacity remains
to be determined.
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